Low-dose vitamin K therapy in excessively anticoagulated patients: A dose-finding study

Journal of Thrombosis and Thrombolysis

Volumn 4, Issue 2, 1997, Pages 289-292

  Brophy, Mary Therese ^a   Fiore, Louis David ^a   Deykin, Daniel ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Overdose; Vitamin K; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030999764     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008811421946     Document Type: Article

References (18)

1. Levine MN, Hirsh J, Landefeld S, Roskob G. Hemorrhagic complications of anticoagulant treatment. Chest 1992; 102(Suppl):3525-3635.
2. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993;95:315.
3. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102:312S-326S.
4. Stults BM, Dere WH, Caine TH. Long-term anticoagulation: Indications and management. West J Med 1989;151: 414-429.
5. Andersen P, Godal HC. Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K. Acta Med Scand 1975;198:269-270.
6. Taberner DA, Thomson JM, Poller L. Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal. Br Med J 1976;2:83-85.
7. Shetty HGM, Backhouse G, Bentley DP, Routledge PH. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K. Thomb Haemost 1992;67: 13-15.
8. Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982;307:1676-1681.
9. Turpie AGG, Gunstensen J, Hirsh J, et al. Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988;1: 1242-1245.
10. Saour JW, Sieck JO, Mamo LAR, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-432.
11. Altman P, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovas Surg 1991;101:427-431.
12. Pengo V, Banzato A, Garelli E, Zass A, Biasiolo A. Reversal of excessive effect of regular anticoagulation: Low dose of phytonadione (Vitamin K1) compared with warfarin discontinuation. Blood Coagul Fibrinolys 1993;4:739-741.
13. Martin JC. Anaphylactoid reactions and vitamin K. Med J Aust 1991;155:851.
14. Rich EC, Drage CW. Severe complications of intravenous phytondione therapy. Postgrad Med 1982;72:303-306.
15. Rubia J, Grau E, Montserrat I, Zuazu I, Paya A. Anaphylactic shock and vitamin K1. Ann Intern Med 1989;110:943.
16. Lefrere JJ, Girot R. Acute cardiovascular collapse during intravenous vitamin K1 injection. Thromb Haemost 1987; 58:790.
17. Labatut A, Sorbrette F, Virenque CH. Etats de choc lors d'injection de vitamine K. Therapie 1988;43:58.
18. Barash P, Kitahata LM, Mandel S. Acute cardiovascular collapse after intravenous phytonadione. Anesth Anuly 1976;55:304-306.